Protected biopolymers for oral administration and methods of using same
AssigneeTrega Biosciences, Inc.
InventorsManoj Maniar, Steven Mauch
Life of this patent
Estimating the term…
Loading patent…
AssigneeTrega Biosciences, Inc.
InventorsManoj Maniar, Steven Mauch
Estimating the term…
The present invention provides a composition comprising an ion exchange resin and a therapeutically active biopolymer in a form for oral administration. The present invention also provides a composition comprising Amberlite.RTM. IRP-64 and a cytokine regulatory agent having the amino acid sequence: Ac-Nle-Gln-His-(D)Phe-Arg-(D)Trp-Gly-NH.sub.2, in a form for oral administration. The present invention further provides a method of protecting a therapeutically active biopolymer from degradation by forming a complex of the biopolymer and an ion exchange resin. In addition, the present invention provides a method of reducing or inhibiting the severity of a pathological condition by orally administering a therapeutically effective dose of the composition.
A composition of matter, comprising an ion-exchange resin and an oppositely charged cytokine regulatory agent (CRA) in a form for oral administration, wherein the CRA has the amino acid sequence ##STR6## H, COCH.sub.3, or absent;
A method for protecting a cytokine regulatory agent from degradation in the gastrointestinal system, comprising forming a complex comprising an ion-exchange resin and an oppositely charged cytokine regulatory agent (CRA) having the amino acid sequence
Dependencies are inferred from the claim text.